Back to Annual Meeting Page
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
|
Back to Annual Meeting Page
|
133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA |
|
|
4175.0: Tuesday, December 13, 2005: 2:30 PM-3:30 PM | |||
Poster | |||
| |||
| Learning Objectives: See individual abstracts | |||
| Risky injection and hygiene practices associated with hepatitis A, B, and C infection in IDUs in Long Beach, CA Grace L. Reynolds, DPA, Dennis G. Fisher, PhD, Adi Jaffe, BA, Christine Willey, MA, Diana Fernandez, BS | |||
| Risk behaviors and the transmission of HIV, hepatitis B and hepatitis C among injecting drug users in Georgia Ekaterine Shapatava, Carlos Del Rio, MD, Kenrad Nelson, MD, Tengiz Tsertsvadze | |||
| Personal network characteristics associated with transition to heroin injection Jesus Sanchez, PhD, Dale D. Chitwood, PhD, Dixie Koo, MS | |||
| Trajectories in injection drug use Jennifer Jackson Bloom, MPH, Stephen E. Lankenau, PhD, Bill Sanders, PhD, Susan Hathazi, BS | |||
| Predictors of sex risk among drug injectors and crack smokers Sherry Deren, PhD, Shiela M. Strauss, PhD, Sung-Yeon Kang, PhD, Hector M. Colon, PhD, Rafaela Robles, EdD | |||
| Interventions to reduce sex-related HIV risks for women drug injectors: A systematic review Traci C. Green, MSc, Enrique R. Pouget, Jeannette R. Ickovics, PhD | |||
| Intermediate harms and benefits of hepatitis C screening Mary Jo Trepka, MD, MSPH, Guoyan Zhang, MD, MPH, Fermin Leguen, MD, MPH, Robert Malow, PhD, Mario De La Rosa, PhD | |||
| Substance use and HIV risk behaviors among transgender women Tooru Nemoto, PhD, Jeanne Sevelius, PhD, JoAnne Keatley, MSW, Mary Hsueh, Jennifer Usher, Ari Rinzler, Kathryn Steuerman, Andrea Horne, Shakira Garr | |||
| Drug treatment program staff's self efficacy in helping their clients with HCV issues Shiela M. Strauss, PhD, Janetta M. Astone-Twerell, PhD, Corrine E. Munoz-Plaza, MPH, Don C. Des Jarlais, PhD, Marya Viorst Gwadz, PhD, Holly Hagan, PhD, Andrew Osborne, MS, Andrew Rosenblum, PhD | |||
| Retention in methadone treatment: Duration and severity of opiate abuse, and methadone dose Lev S. Sverdlov, MD, PhD, DMS, Leigh Ainslie Henderson, PhD, Thomas M. Brady, PhD | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | Alcohol, Tobacco, and Other Drugs | ||
| Endorsed by: | Public Health Education and Health Promotion; Public Health Nursing | ||
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA